Here are the news:
Excited to share that Zippin Bio has been awarded a $700K NIH Phase I SBIR grant to advance our delivery platform for crossing the blood–brain barrier (BBB), a major step toward safe and scalable treatments for neurological diseases.
Huge thank you to NINDS for believing in our approach, and to our incredible team and mentors for their relentless work and support.